Free Trial

Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Allied Healthcare Products, Inc. stock logo
AHPI
Allied Healthcare Products
$0.01
$0.00
$3.46
$16K-2.3951,674 shsN/A
Conformis, Inc. stock logo
CFMS
Conformis
$2.26
$2.25
$1.05
$7.25
$17.80M1.3999,585 shs7,000 shs
CollPlant Biotechnologies Ltd. stock logo
CLGN
CollPlant Biotechnologies
$5.61
$5.69
$4.22
$8.90
$64.19M0.15,593 shs9,025 shs
Histogenics Corp stock logo
HSGX
Histogenics
$1.70
-1.7%
$1.33
$0.08
$1.43
$160.82M3.19.06 million shs3.79 million shs
NanoVibronix, Inc. stock logo
NAOV
NanoVibronix
$0.81
$0.79
$0.68
$4.23
$2.25M1.4524,654 shs16,846 shs
Elon Musk's Next Move Cover

Wondering when you'll finally be able to invest in SpaceX, StarLink, or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Allied Healthcare Products, Inc. stock logo
AHPI
Allied Healthcare Products
0.00%0.00%0.00%0.00%+149,500.00%
Conformis, Inc. stock logo
CFMS
Conformis
0.00%0.00%0.00%0.00%+100.00%
CollPlant Biotechnologies Ltd. stock logo
CLGN
CollPlant Biotechnologies
+0.09%-2.60%-5.71%+11.98%-23.88%
Histogenics Corp stock logo
HSGX
Histogenics
-1.73%-2.86%+27.82%+96.99%+259.86%
NanoVibronix, Inc. stock logo
NAOV
NanoVibronix
+0.47%+4.76%+10.45%-15.26%-78.25%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Allied Healthcare Products, Inc. stock logo
AHPI
Allied Healthcare Products
N/AN/AN/AN/AN/AN/AN/AN/A
Conformis, Inc. stock logo
CFMS
Conformis
N/AN/AN/AN/AN/AN/AN/AN/A
CollPlant Biotechnologies Ltd. stock logo
CLGN
CollPlant Biotechnologies
1.2383 of 5 stars
3.53.00.00.01.10.00.6
Histogenics Corp stock logo
HSGX
Histogenics
N/AN/AN/AN/AN/AN/AN/AN/A
NanoVibronix, Inc. stock logo
NAOV
NanoVibronix
N/AN/AN/AN/AN/AN/AN/AN/A

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Allied Healthcare Products, Inc. stock logo
AHPI
Allied Healthcare Products
N/AN/AN/AN/A
Conformis, Inc. stock logo
CFMS
Conformis
N/AN/AN/AN/A
CollPlant Biotechnologies Ltd. stock logo
CLGN
CollPlant Biotechnologies
3.00
Buy$11.0096.08% Upside
Histogenics Corp stock logo
HSGX
Histogenics
N/AN/AN/AN/A
NanoVibronix, Inc. stock logo
NAOV
NanoVibronix
N/AN/AN/AN/A

Current Analyst Ratings

Latest CFMS, CLGN, AHPI, HSGX, and NAOV Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/30/2024
CollPlant Biotechnologies Ltd. stock logo
CLGN
CollPlant Biotechnologies
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$11.00 ➝ $11.00
4/5/2024
CollPlant Biotechnologies Ltd. stock logo
CLGN
CollPlant Biotechnologies
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$11.00
(Data available from 6/4/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Allied Healthcare Products, Inc. stock logo
AHPI
Allied Healthcare Products
$27.05M0.00N/AN/A$1.30 per share0.00
Conformis, Inc. stock logo
CFMS
Conformis
$57.06M0.31N/AN/A$4.07 per share0.56
CollPlant Biotechnologies Ltd. stock logo
CLGN
CollPlant Biotechnologies
$10.96M5.86N/AN/A$2.47 per share2.27
Histogenics Corp stock logo
HSGX
Histogenics
N/AN/AN/AN/A($0.01) per shareN/A
NanoVibronix, Inc. stock logo
NAOV
NanoVibronix
$2.28M0.99N/AN/A$1.95 per share0.42

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Allied Healthcare Products, Inc. stock logo
AHPI
Allied Healthcare Products
-$5.36M-$1.34N/AN/AN/AN/AN/AN/AN/A
Conformis, Inc. stock logo
CFMS
Conformis
-$50.47M-$5.61N/AN/AN/A-72.72%-86.46%-47.65%N/A
CollPlant Biotechnologies Ltd. stock logo
CLGN
CollPlant Biotechnologies
-$7.02M-$0.68N/AN/AN/A-70.58%-24.74%-20.90%8/22/2024 (Estimated)
Histogenics Corp stock logo
HSGX
Histogenics
-$8.64M-$0.79N/AN/AN/A-34.96%18.40%N/A
NanoVibronix, Inc. stock logo
NAOV
NanoVibronix
-$3.71M-$1.69N/AN/A-112.35%-95.96%-53.14%8/9/2024 (Estimated)

Latest CFMS, CLGN, AHPI, HSGX, and NAOV Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
4/8/2024Q4 2023
NanoVibronix, Inc. stock logo
NAOV
NanoVibronix
N/A-$0.39-$0.39-$0.39N/A$1.18 million
4/4/2024Q4 2023
CollPlant Biotechnologies Ltd. stock logo
CLGN
CollPlant Biotechnologies
N/A-$0.42-$0.42-$0.42N/A$0.30 million

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Allied Healthcare Products, Inc. stock logo
AHPI
Allied Healthcare Products
N/AN/AN/AN/AN/A
Conformis, Inc. stock logo
CFMS
Conformis
N/AN/AN/AN/AN/A
CollPlant Biotechnologies Ltd. stock logo
CLGN
CollPlant Biotechnologies
N/AN/AN/AN/AN/A
Histogenics Corp stock logo
HSGX
Histogenics
N/AN/AN/AN/AN/A
NanoVibronix, Inc. stock logo
NAOV
NanoVibronix
N/AN/AN/AN/AN/A

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Allied Healthcare Products, Inc. stock logo
AHPI
Allied Healthcare Products
N/AN/AN/A
Conformis, Inc. stock logo
CFMS
Conformis
0.64
5.07
3.30
CollPlant Biotechnologies Ltd. stock logo
CLGN
CollPlant Biotechnologies
N/A
7.15
6.96
Histogenics Corp stock logo
HSGX
Histogenics
N/A
4.05
4.05
NanoVibronix, Inc. stock logo
NAOV
NanoVibronix
N/A
2.45
1.38

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Allied Healthcare Products, Inc. stock logo
AHPI
Allied Healthcare Products
4.15%
Conformis, Inc. stock logo
CFMS
Conformis
10.31%
CollPlant Biotechnologies Ltd. stock logo
CLGN
CollPlant Biotechnologies
21.69%
Histogenics Corp stock logo
HSGX
Histogenics
40.35%
NanoVibronix, Inc. stock logo
NAOV
NanoVibronix
16.39%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Allied Healthcare Products, Inc. stock logo
AHPI
Allied Healthcare Products
1894.01 million3.81 millionNot Optionable
Conformis, Inc. stock logo
CFMS
Conformis
2957.88 million7.58 millionNot Optionable
CollPlant Biotechnologies Ltd. stock logo
CLGN
CollPlant Biotechnologies
7511.45 million10.35 millionOptionable
Histogenics Corp stock logo
HSGX
Histogenics
4994.60 millionN/ANot Optionable
NanoVibronix, Inc. stock logo
NAOV
NanoVibronix
102.78 million2.68 millionNot Optionable

CFMS, CLGN, AHPI, HSGX, and NAOV Headlines

Recent News About These Companies

NanoVibronix Issues Letter to Stockholders
NanoVibronix Issues Letter to Stockholders
NanoVibronix, Inc. (NAOV)
NanoVibronix Inc NAOV
NanoVibronix Featured in Your Bladder Health Magazine

New MarketBeat Followers Over Time

Media Sentiment Over Time

Company Descriptions

Allied Healthcare Products logo

Allied Healthcare Products

NASDAQ:AHPI
Allied Healthcare Products, Inc. engages in manufacturing respiratory products used in the health care industry in hospitals and alternate site settings, including sub-acute care facilities, home health care and emergency medical care. Its product line includes respiratory care products, medical gas equipment, and emergency medical products. The company was founded in 1979 and is headquartered in St. Louis, MO.
Conformis logo

Conformis

NASDAQ:CFMS
Conformis, Inc., a medical technology company, develops, manufactures, and sells patient-specific products and instrumentation. The company offers personalized knee replacement products, including iUni, iDuo, iTotal CR, and iTotal PS, as well as provides iTotal Identity and Identity Imprint knee replacement products. It also offers Conformis Hip System and Cordera hip replacement, which are hip replacement products; and iJigs, a personalized single-use patient-specific instrumentation. The company markets and sells its products to orthopedic surgeons, hospitals, and other medical facilities through sales force, independent sales representatives, and distributors in the United States, Germany, the United Kingdom, Austria, Ireland, Switzerland, Spain, Portugal, the Netherlands, Belgium, the Dutch Antilles, Suriname, Australia, Brazil, the United Arab Emirates, the Sultanate of Oman, Italy, Poland, and other markets. Conformis, Inc. was incorporated in 2004 and is headquartered in Billerica, Massachusetts.
CollPlant Biotechnologies logo

CollPlant Biotechnologies

NASDAQ:CLGN
CollPlant Biotechnologies Ltd., a regenerative and aesthetic medicine company, focuses on three-dimensional (3D) bioprinting of tissues and organs, and medical aesthetics in the United States, Canada, Israel, Europe, and internationally. Its products are based on recombinant type I human collagen that is produced with its proprietary plant based genetic engineering technology. The company's products include BioInks for 3D printing of tissues and organs; dermal filler and soft tissue fillers for treating wrinkles; 3D Bioprinted breast implants for regeneration of breast tissue; VergenixSTR, a soft tissue repair matrix intended for the treatment of tendinopathy; and VergenixFG, an advanced wound care product for the treatment of deep surgical incisions and wounds, including diabetic ulcers, venous and pressure ulcers, burns, bedsores, and other chronic wounds; as well as develops injectable breast implants and 3D bioprinted regenerative soft tissue matrix for use in breast reconstruction procedures. It has collaboration agreements with Advanced Regenerative Manufacturing Institute; RegenMed Development Organization; International Society for Biofabrication; AbbVie; and STEMCELL Technologies. The company was formerly known as CollPlant Holdings Ltd. and changed its name to CollPlant Biotechnologies Ltd. in June 2019. The company was founded in 2004 and is headquartered in Rehovot, Israel.
Histogenics logo

Histogenics

NASDAQ:HSGX
Histogenics Corporation develops restorative cell therapies that would offer rapid-onset pain relief and restored function. The company was founded in 2000 and is headquartered in Waltham, Massachusetts.
NanoVibronix logo

NanoVibronix

NASDAQ:NAOV
NanoVibronix, Inc., through its subsidiary, NanoVibronix Ltd., focuses on the manufacture and sale of noninvasive biological response-activating devices that target biofilm prevention, wound healing, and pain therapy. Its product portfolio includes UroShield, an ultrasound-based product to prevent bacterial colonization and biofilm in urinary catheters, enhance antibiotic efficacy, and decrease pain and discomfort associated with urinary catheter use. The company also offers PainShield, a patch-based therapeutic ultrasound technology to treat pain, muscle spasm, and joint contractures; and WoundShield, a patch-based therapeutic ultrasound device intended to facilitate tissue regeneration and wound healing by using ultrasound to increase local capillary perfusion and tissue oxygenation. It sells its products directly to patients, as well as through distributor agreements in the United States, Israel, Europe, Australia, India, and internationally. The company was incorporated in 2003 and is headquartered in Elmsford, New York.